Filing Details
- Accession Number:
- 0001213900-21-019674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 16:31:49
- Reporting Period:
- 2021-03-31
- Accepted Time:
- 2021-04-01 16:31:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767226 | J Timothy Schroeder | C/O Inmune Bio Inc., 1200 Prospect Street, Suite 525 La Jolla CA 92037 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-31 | 10,000 | $11.95 | 156,667 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- The sales reported in this Form 4 were effected in the open market outside of a 10b5 plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $11.59 to $12.47, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
- These shares of Common Stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares.